None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL. Tavori H, Su YR, Yancey PG, Giunzioni I, Wilhelm AJ, Blakemore JL, Zabalawi M, Linton MF, Sorci-Thomas MG, Fazio S (2015) J Lipid Res 56(3): 635-643
    › Primary publication · 25593328 (PubMed) · PMC4340310 (PubMed Central)
  2. Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertension. Monahan K, Scott TA, Su YR, Lenneman CG, Zhao DX, Robbins IM, Hemnes AR (2013) Pulm Circ 3(2): 345-9
    › Primary publication · 24015334 (PubMed) · PMC3757828 (PubMed Central)
  3. Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy. Wells QS, Becker JR, Su YR, Mosley JD, Weeke P, D'Aoust L, Ausborn NL, Ramirez AH, Pfotenhauer JP, Naftilan AJ, Markham L, Exil V, Roden DM, Hong CC (2013) Circ Cardiovasc Genet 6(4): 317-26
    › Primary publication · 23861363 (PubMed) · PMC3895490 (PubMed Central)
  4. ACAT1 deficiency increases cholesterol synthesis in mouse peritoneal macrophages. Dove DE, Su YR, Swift LL, Linton MF, Fazio S (2006) Atherosclerosis 186(2): 267-74
    › Primary publication · 16144700 (PubMed)
  5. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1. Su YR, Dove DE, Major AS, Hasty AH, Boone B, Linton MF, Fazio S (2005) Circulation 111(18): 2373-81
    › Primary publication · 15851589 (PubMed)
  6. ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages. Dove DE, Su YR, Zhang W, Jerome WG, Swift LL, Linton MF, Fazio S (2005) Arterioscler Thromb Vasc Biol 25(1): 128-34
    › Primary publication · 15499044 (PubMed)
  7. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, Linton MF (2003) Circulation 108(18): 2258-63
    › Primary publication · 14581413 (PubMed)
  8. Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters. Su YR, Ishiguro H, Major AS, Dove DE, Zhang W, Hasty AH, Babaev VR, Linton MF, Fazio S (2003) Mol Ther 8(4): 576-83
    › Primary publication · 14529830 (PubMed)
  9. Rapid quantification of murine ABC mRNAs by real time reverse transcriptase-polymerase chain reaction. Su YR, Linton MF, Fazio S (2002) J Lipid Res 43(12): 2180-7
    › Primary publication · 12454281 (PubMed)
  10. Isoform-specific effects of apolipoprotein E on atherogenesis: gene transduction studies in mice. Yoshida H, Hasty AH, Major AS, Ishiguro H, Su YR, Gleaves LA, Babaev VR, Linton MF, Fazio S (2001) Circulation 104(23): 2820-5
    › Primary publication · 11733401 (PubMed)
  11. Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice. Major AS, Dove DE, Ishiguro H, Su YR, Brown AM, Liu L, Carter KJ, Linton MF, Fazio S (2001) Arterioscler Thromb Vasc Biol 21(11): 1790-5
    › Primary publication · 11701467 (PubMed)